Cardoso, Bruno AntónioNeparidze, Natalia2025-04-022025-04-022025-01-242813-3935http://hdl.handle.net/10400.14/52896engBcl-2 inhibitionBone marrowCAR T-cell therapyCCUSHematological malignanciesMultiple myelomaEditorial: two decades of targeted therapies in hematology: new targets and novel combinationseditorial10.3389/frhem.2025.154898486000047545